Nasar Ata | Neurology | Best Researcher Award

Published on by Neuroscientists

Mr. Nasar Ata | Neurology | Best Researcher Award

Dr. S. M. Nasar Ata is a researcher in the Department of Neurology at Henry Ford Hospital, Detroit, USA, specializing in artificial intelligence applications in neuroscience. His work focuses on developing machine learning and soft computing–based algorithms such as CNN, ANN, SVM, and MLR for detecting and predicting brain-based disorders, including Multiple Sclerosis. He integrates metabolomics and imaging clinical data to identify biomarkers and construct predictive models for neurological and metabolic diseases. Dr. Ata collaborates with research centers such as JNMC and IBRC AMU on brain tumor prediction from MRI data and with RCDR AMU on diabetes-related model development. His research contributions include several submitted papers on metabolite prediction, deep learning in brain tumor detection, and molecular mechanisms underlying neurodegeneration and cancer. He has also authored the textbook Basics of Bio-Sciences and actively participates in scientific discussions and editorial work. With 3 published documents, 7 citations, and an h-index of 2, Dr. Ata’s growing research profile reflects his commitment to advancing data-driven neurological diagnostics through AI and biostatistical innovation.

Profiles: Scopus | Research Gate

Featured Publication

Corrigendum to “Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data” [Multiple Sclerosis and Related Disorders, 92, 105942 (2024)]. (2024). Multiple Sclerosis and Related Disorders, 95, 106321.

Karen Kikuta | Developmental Neuroscience | Best Researcher Award

Published on by Neuroscientists

Ms. Karen Kikuta | Developmental Neuroscience | Best Researcher Award

Ms. Karen Kikuta | UCLA David Geffen School of Medicine | United States

Ms. Karen Kikuta is an accomplished MD Candidate at the UCLA David Geffen School of Medicine with expertise in neuroscience, immunology, and global health research. She earned her B.S. in Neuroscience with minors in Public Health and Biology from Santa Clara University and conducted advanced immunological studies at Stanford University’s Binns Program for Cord Blood Research, investigating immune cell subsets using flow cytometry and single-cell RNA sequencing. Her work has resulted in publications in high-impact journals, including Frontiers in Immunology and the International Journal of Infectious Diseases. Karen has contributed to seven major research projects spanning neurodevelopment, infectious disease, and translational medicine, notably pioneering studies on antenatal Zika virus exposure and its long-term neurobehavioral and cardiac outcomes in children. Her research portfolio includes 2 published documents, 45 citations, and an h-index of 2. She has presented findings at national and international conferences, reflecting her dedication to bridging laboratory discoveries with clinical application. As a member of the American Academy of Neurology and the American Neurological Association, Karen is committed to integrating scientific innovation with compassionate care to advance understanding and treatment of neuroinfectious and developmental disorders.

Profiles: Scopus | Orcid | Research Gate | Linked In

Featured publication

Kikuta, K., Hernandez, C. J., Dunshee de Abranches, A., Damasceno, L., de Britto, J. A., Jardim Duarte, C., Vasconcelos, Z., Zin, A., Brasil, P., Moreira, M. E., & Nielsen-Saines, K. (2025). Academic and social-behavioral assessment in a prospective cohort of normocephalic school-aged children with antenatal Zika virus exposure. International Journal of Infectious Diseases, 159, Article 108026.

Wilfred Angie Abia | Developmental Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Wilfred Angie Abia | Developmental Neuroscience | Best Researcher Award

Dr. Wilfred Angie Abia |  University of Yaounde 1 | Cameroon

Wilfred Angie Abia is an accomplished biochemist and food safety toxicologist whose career bridges Africa and Europe through impactful teaching, research, and international collaborations. His academic foundation in medical biochemistry, nutrition, and toxicology has evolved into a distinguished career specializing in food contaminants, mycotoxin biomonitoring, fraud detection, and risk assessment. He has held influential postdoctoral and leadership positions in projects addressing agri-food safety and consumer health protection. His contributions span mycotoxicology, food fraud prevention, One Health research, and climate-related food safety challenges. Beyond research, he plays an important role as a senior lecturer and mentor, advancing both academic excellence and professional training in food safety.

Profile

Google Scholar
Orcid
Scopus

Early Academic Pursuits

Wilfred Angie Abia began his academic journey with a strong foundation in biochemistry, focusing on medical laboratory technology, nutritional sciences, and food safety. His doctoral studies at the University of Yaoundé I provided him with advanced expertise in food contaminants, safety, and biomonitoring of multimycotoxin exposures. His early academic years were marked by interdisciplinary training that connected biochemistry, nutrition, toxicology, and public health, setting the stage for his specialized career in agri-food safety and toxicology.

Professional Endeavors

His professional career spans teaching, research, and project management across multiple institutions and international collaborations. He has held postdoctoral fellowships and senior research positions in Africa, Europe, and the United Kingdom, where he advanced projects on food safety, toxicology, and fraud detection. His work at Queen’s University Belfast included leadership roles in large-scale European initiatives, where he served as both a researcher and project manager. As a Senior Lecturer of Biochemistry and Food Safety/Toxicology at the University of Yaoundé I, he combines teaching, mentorship, and research with program coordination responsibilities, shaping the next generation of food safety professionals.

Contributions and Research Focus

Abia’s research focuses on food contaminants, safety, and human health with a special emphasis on mycotoxicology. He has pioneered studies in exposure assessment, biomarker development, and human biomonitoring, particularly in vulnerable populations. His work extends to food integrity, authenticity, fraud detection, and traceability, ensuring consumer health protection. He has contributed significantly to toxicological risk assessments of chemicals in food, drugs, and the environment, while also addressing broader themes such as climate change, food security, and the One Health approach. His unique contributions include research into the neurotoxicology of mycotoxins, highlighting the intersection of food safety and neuroscience.

Accolades and Recognition

Throughout his career, Abia has been recognized through prestigious international research fellowships and visiting scholar positions in leading research centers across Europe and Africa. His involvement in high-impact projects such as MycoMarker and FoodSafer underscores his leadership in global food safety initiatives. His achievements are further strengthened by professional certifications, including specialized training in food fraud prevention, which demonstrate his commitment to continuous professional growth and excellence in his field.

Impact and Influence

His work has had a profound impact on advancing food safety research, shaping policies, and protecting public health. By bridging biochemistry with toxicology, agri-food safety, and environmental sciences, he has influenced how food contaminants and fraud are detected and managed. His role as a lecturer and mentor ensures that his expertise is transmitted to students and young researchers who will continue to advance the field. His contributions also extend to policy and science diplomacy, where he actively promotes interdisciplinary collaboration for sustainable solutions in food and health security.

Legacy and Future Contributions

Abia’s legacy lies in his dedication to safeguarding food systems, advancing toxicological research, and promoting interdisciplinary approaches that connect human, animal, and environmental health. His work in mycotoxin biomonitoring and neurotoxicology offers critical insights into the hidden health risks of food contamination. Looking ahead, his future contributions are likely to expand in areas of food fraud prevention, climate-smart agriculture, and One Health frameworks, ensuring resilient food systems for global populations. His combination of research excellence, teaching, and science diplomacy positions him as a thought leader in shaping the future of food safety and toxicology.

Publications

  • Title: Determination of multi-mycotoxin occurrence in cereals, nuts and their products in Cameroon by liquid chromatography tandem mass spectrometry (LC-MS/MS)
    Authors: WA Abia, B Warth, M Sulyok, R Krska, AN Tchana, PB Njobeh, MF Dutton, …
    Year: 2013

  • Title: Mycotoxin exposure in rural residents in northern Nigeria: A pilot study using multi-urinary biomarkers
    Authors: CN Ezekiel, B Warth, IM Ogara, WA Abia, VC Ezekiel, J Atehnkeng, …
    Year: 2014

  • Title: Development and validation of a rapid multi‐biomarker liquid chromatography/tandem mass spectrometry method to assess human exposure to mycotoxins
    Authors: B Warth, M Sulyok, P Fruhmann, H Mikula, F Berthiller, R Schuhmacher, …
    Year: 2012

  • Title: Bio-monitoring of mycotoxin exposure in Cameroon using a urinary multi-biomarker approach
    Authors: WA Abia, B Warth, M Sulyok, R Krska, A Tchana, PB Njobeh, PC Turner, …
    Year: 2013

  • Title: Ultra-sensitive, stable isotope assisted quantification of multiple urinary mycotoxin exposure biomarkers
    Authors: B Šarkanj, CN Ezekiel, PC Turner, WA Abia, M Rychlik, R Krska, M Sulyok, …
    Year: 2018

  • Title: Low doses of mycotoxin mixtures below EU regulatory limits can negatively affect the performance of broiler chickens: A longitudinal study
    Authors: O Kolawole, A Graham, C Donaldson, B Owens, WA Abia, J Meneely, …
    Year: 2020

  • Title: Urinary analysis reveals high deoxynivalenol exposure in pregnant women from Croatia
    Authors: B Šarkanj, B Warth, S Uhlig, WA Abia, M Sulyok, T Klapec, R Krska, …
    Year: 2013

Conclusion

Wilfred Angie Abia’s work exemplifies a rare integration of scientific expertise, international leadership, and educational impact. His contributions to food safety, toxicology, and agri-food research not only safeguard public health but also strengthen global food systems. With his continued focus on innovation, interdisciplinary approaches, and capacity building, he stands as a key figure in shaping the future of food safety science and policy worldwide.

Rania Awadi | Developmental Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Rania Awadi | Developmental Neuroscience | Best Researcher Award

Dr. Rania Awadi |  Higher Institute of Medical Technologies of Tunis | Tunisia

Dr. Rania Awadi is a biophysics and medical imaging researcher whose work centers on cardiac biomechanics and non-invasive diagnostic techniques. With a PhD in biophysics and medical imaging, she has conducted advanced studies on left ventricle biomechanics using finite element modelling and gained international experience through research internships in France and collaborations with leading medical institutions in Tunisia. Her research expertise lies in cardiovascular MRI, image processing, and myocardial strain assessment, particularly in pediatric populations where diagnostic challenges are more pronounced. Among her significant contributions is a study on Duchenne Muscular Dystrophy, where she applied cardiac MRI feature tracking to identify early subclinical myocardial dysfunction without contrast agents, an advancement with meaningful clinical impact.

Profile

Google Scholar

Early Academic Pursuits

From the outset of her academic journey, Dr. Rania Awadi cultivated a strong foundation in biophysics, medical physics, and medical imaging. Her doctoral studies at the Higher Institute of Medical Technologies of Tunis were marked by a deep focus on the biomechanics of the left ventricle, where she applied finite element modelling to explore complex cardiac dynamics. Early research internships at prestigious institutions such as IMT Atlantique in France and Sorbonne University enriched her academic profile, enabling her to refine her expertise in advanced imaging and computational modelling techniques.

Professional Endeavors

Building upon her academic training, Dr. Awadi advanced into professional roles that merged teaching and research. She joined the Higher Institute of Medical Technologies of Tunis as a lecturer in biomechanics, where she has contributed to shaping future professionals in medical physics and imaging. Her work also extended to clinical collaborations, including her involvement with the Principal Military Hospital of Tunis and Monji Ben Hmida Center, emphasizing translational research that bridges scientific innovation with patient care.

Contributions and Research Focus

Dr. Awadi’s contributions to medical science are anchored in cardiovascular imaging and cardiac biomechanics. Her expertise lies in cardiac magnetic resonance imaging, image processing, and computational modelling, with a particular focus on assessing myocardial strain. She has addressed the unique challenges of pediatric populations, where smaller heart sizes, higher heart rates, and variability in strain demand precise methodologies. Her research has sought to make early diagnosis more accessible and reliable, especially in vulnerable groups affected by genetic and muscular disorders.

Pioneering Research on Duchenne Muscular Dystrophy

Among her notable achievements, Dr. Awadi conducted a pioneering study on myocardial strain assessment for early diagnosis of Duchenne Muscular Dystrophy in pediatric patients using cardiac MRI. Through the application of feature tracking techniques, she demonstrated the feasibility of detecting subclinical myocardial dysfunction without the use of contrast agents, reducing risks in younger patients. Her findings, published in Applied Sciences, underscored significant associations between myocardial strain parameters and structural cardiac changes, providing a non-invasive tool for monitoring disease progression in affected children.

Accolades and Recognition

Dr. Awadi’s scholarly contributions have been recognized in the international research community through publication in high-impact journals. Her work in Applied Sciences has strengthened her standing as an emerging researcher in cardiac imaging and biomechanics. Her collaborations with European and Tunisian research institutions reflect her growing reputation as a scientist capable of fostering cross-border innovation in medical imaging and biomechanics.

Impact and Influence

The impact of Dr. Awadi’s research extends beyond academic recognition to meaningful influence on clinical practices. By offering new insights into myocardial strain assessment, she has contributed to refining diagnostic approaches for conditions like Duchenne Muscular Dystrophy, where early intervention can significantly alter outcomes. Her teaching and mentorship also shape a new generation of researchers and clinicians, further amplifying the reach of her work across academia and healthcare.

Legacy and Future Contributions

Looking ahead, Dr. Awadi’s career continues to chart a path of scientific advancement and clinical relevance. With expertise spanning biomechanics, MRI, and computational modelling, she is poised to deepen investigations into cardiac function across diverse patient populations. Her future contributions are expected to expand the frontiers of non-invasive diagnostics, ensuring that her legacy in cardiovascular biomechanics and imaging is defined by both innovation and tangible impact on patient health.

Publications

Numerical study of two microwave antennas dedicated to superficial cancer hyperthermia
N. Benameur, R. Awadi, A. Bouabidi, M.A. Mohammed, M.U. Rehman, … – 2024

A quasi-static biomechanical model of the human myocardium based on Cardiac Magnetic Resonance images
R. Awadi, N. Benameur, T. Kraiem, L. Salam – 2023

Comparison of Left Ventricle Deformation Analysis Using Abaqus and CVi42 Software: Insights from Healthy Subjects and patients with Myocardial Infarction
R. Awadi, N. Benameur, A. Sleimi, L. Salam – 2025

Myocardial Strain Assessment for Early Duchenne Muscular Dystrophy Diagnosis in Pediatric Patients Using Cardiac MRI
R. Awadi, N. Benameur, H. Hafsi, T.B. Younes, Y. Arous, S. Labidi, … – 2024

Left Ventricle Wall Motion Abnormalities Detection in Cardiac MRI
N. Benameur, R. Awadi, R. Mahmoudi, M. Deriche, M. Al Betar – 2023

Finite Element of Biomechanical Model of the Human Myocardium from a Cardiac MRI Images
A. Rania, N. Benameur, T. Kraiem, S. Labidi – 2022

of the Human Myocardium from a Cardiac MRI Images
A. Rania, N. Benameur, T. Kraiem, S. Labidi – 2022

Conclusion

Dr. Awadi’s career reflects a blend of academic rigor, professional dedication, and innovative research that addresses pressing clinical needs in pediatric cardiology. Her work has advanced the understanding of myocardial strain assessment, offering tools that improve early diagnosis and patient care. Through her teaching, collaborations, and published research, she has established herself as a promising figure in cardiac imaging and biomechanics. Looking forward, her contributions are set to further bridge the gap between research and clinical application, reinforcing her role as a driving force in the development of non-invasive diagnostic technologies.

Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Georgia Kaiafa, Medical School, Aristotle University of Thessaloniki,  Greece.

Dr. Georgia Kaiafa is a distinguished hematologist and academician whose career spans clinical excellence, impactful research, and dedicated teaching. A graduate of Aristotle University of Thessaloniki, she earned her MBBS in 1987, Board Certification in Hematology in 1996, and completed her Doctorate in 2005. Her academic roles have progressed from Lecturer to Associate Professor of Hematology and Thromboembolic Diseases, with a longstanding association at AHEPA University Hospital.

Profile

Scopus

 

🎓 Early Academic Pursuits

Georgia Kaiafa began her academic journey in medicine at the prestigious Aristotle University of Thessaloniki, enrolling in the Medical School in 1980. Her foundational training was marked by determination and intellectual rigor, culminating in the completion of her MBBS in 1987. A steadfast commitment to advanced education led her to earn her Board Certification in Haematology by 1996, and later, she successfully defended her Doctorate thesis in 2005. These formative years reflect her deep-rooted passion for understanding hematological science and its clinical applications.

🧬 Professional Endeavors in Hematology

Her professional journey has been nothing short of inspiring, anchored in both clinical excellence and academic growth. Georgia Kaiafa has served in several academic ranks, beginning as a Lecturer in Hematology from 2007 to 2015, advancing to Assistant Professor until 2021, and currently holding the esteemed position of Associate Professor of Hematology and Thromboembolic Diseases. She is affiliated with AHEPA University Hospital’s Hematology Department, a major center of excellence in Greece. Her expertise was further enriched by her tenure as a Visiting Research Associate at King’s College Hospital in London in 2012, where she gained valuable international exposure. Since 2005, she has also played a leadership role as a Coordinator in the Northern Greece Office of the Health Sector, bridging academic medicine and healthcare policy.

🩸 Contributions and Research Focus

Georgia Kaiafa has devoted her scholarly efforts to advancing the understanding of thrombosis, thromboembolic disorders, and hematological malignancies. With her contributions to over 95 peer-reviewed international journal publications and participation as a Principal Investigator in 26 research trials, she has carved out a niche in evidence-based hematological research. Her investigations have deeply influenced protocols and practices in vascular pharmacology, hematologic diagnostics, and the clinical management of thrombotic conditions. She is also a prominent educator, mentoring Ph.D. candidates and contributing to postgraduate programs for both Greek and international students.

🏆 Accolades and Recognition

Her scientific contributions have not gone unnoticed. Georgia Kaiafa has received significant national acclaim, including the 1st Prize Award for Best Paper at the Pan-Hellenic Haematology Conference in 2008 and again at the 1st Conference of Internal Medicine of Northern Greece in 2015. These accolades affirm her research excellence and clinical insight. Her expertise has earned her memberships in elite national and international medical societies, including the Hellenic Stroke Organization and the European Stroke Organization, as well as a respected position in the Excellence of Thrombosis initiative.

🌍 Impact and Influence

Beyond academia and clinical service, Kaiafa has exerted influence on multiple scientific fronts. As a reviewer for prominent journals such as Thrombosis Research, Anemia, Case Reports in Hematology, and the Indian Heart Journal, she ensures high scientific standards in hematologic research worldwide. Her editorial work for both international and Greek journals demonstrates her authority in the field and her dedication to the progression of scientific communication. Her wide-ranging collaborations and committee leadership roles have significantly influenced health education and medical research in Greece and abroad.

📚 Scholarly Engagement and Mentorship

Georgia Kaiafa is not only a prolific researcher but also a passionate mentor and academic contributor. With 23 chapters in medical books, over 130 abstracts in Greek conference proceedings, and nearly 100 abstracts presented in international forums, her voice resonates across the global hematology community. She has mentored and supervised numerous doctoral students, serving on committees for 12 Ph.D. projects and directly supervising five, cultivating the next generation of scientific minds. She has also chaired 22 congress sessions and delivered more than 100 invited talks, emphasizing her respected role as both speaker and thought leader.

🔬 Legacy and Future Contributions

As a seasoned academic and clinical researcher, Georgia Kaiafa continues to shape the future of hematology in Greece and beyond. Her legacy lies in her dual commitment to clinical care and scientific discovery, especially in the realm of thromboembolic diseases and hematologic innovations. Her ongoing involvement in research protocols, editorial responsibilities, and student mentorship assures that her influence will persist. With a solid foundation and a career marked by excellence, her future contributions are likely to further impact hematological sciences and translational medicine globally.

publication

 

  • Title: Monocyte Chemoattractant Protein-1 as a Biomarker in Acute Ischemic Stroke: A Prospective Pilot Study
    Author(s): [Not specified]
    Year: 2025

 

  • Title: Prospective Study of ADAMTS13 and von Willebrand Factor’s Role in the Prediction of Outcomes in Acute Ischemic Stroke
    Author(s): [Not specified]
    Year: 2025

 

  • Title: Antiphospholipid Syndrome: A Comprehensive Clinical Review
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: The Seasonal Distribution of Immune Thrombotic Thrombocytopenic Purpura is Influenced by Geography: Epidemiologic Findings from a Multi-Center Analysis of 719 Disease Episodes
    Author(s): [Not specified]
    Year: 2024

 

  • Title: Current Trends in Stroke Biomarkers: The Prognostic Role of S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Outpatient Management After Hospitalisation for Acute Decompensation of Cirrhosis: A Practical Guide
    Author(s): [Not specified]
    Year: 2024

 

  • Title: Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Post-COVID-19 and Irritable Bowel Syndrome: A Literature Review
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Thyroid Disease and Systemic Lupus Erythematosus
    Author(s): [Not specified]
    Year: 2023

 

🏁 Conclusion

Dr. Georgia Kaiafa embodies the values of academic integrity, scientific advancement, and clinical leadership. Her commitment to both national healthcare development and international scientific collaboration sets her apart. With a strong foundation in research, education, and public health, she not only meets but exceeds the criteria for recognition through the Best Researcher Award. Her body of work stands as a testament to sustained excellence and future promise in hematology and related disciplines.

Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Dr.  Liliana Elena Weimer, Center For Global Health Istituto Superiore di Sanita’ Rome, Italy.

Dr. Liliana Elena Weimer is a highly accomplished physician and clinical researcher , where she has risen to the prestigious Level II “First Researcher” position. Her professional focus lies in clinical trials for infectious diseases, particularly HIV and Hepatitis C. She has played a critical role in major national and international research efforts, including collaborations with the U.S. Clinical Trials Group and leadership of the large-scale PITER cohort involving 25,000 HCV patients. She is known not only for her scientific contributions but also for her humanitarian efforts during the COVID-19 emergency. Among her recognitions is the 1st Prize at the 2019 International Congress on Hepatitis C in Seville. Throughout her career, she has exemplified scientific integrity, dedication, and service to public health.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born on December 19, 1965, in Buenos Aires to Italian parents, Dr. Liliana Elena Weimer embraced her dual heritage and committed herself to a life in medicine and research. With Italian citizenship and deep academic determination, she laid the groundwork for her career by studying medicine, ultimately finding her professional home in Italy. Her academic path, though not fully detailed, clearly led her toward a focus on clinical medicine and infectious diseases, with her earliest professional roles marking the beginning of a lifelong engagement in public health and biomedical research. Her intellectual dedication and international roots later became an asset in global research collaborations.

🩺 Professional Endeavors

Dr. Weimer’s distinguished career spans over three decades at the Italian National Institute of Health (ISS), beginning in 1985. Starting as a dedicated clinical physician, she ascended to Level III researcher status by 1990 and continued to grow into higher ranks, culminating in her success in the national Art. 15 competition for the Level II “First Researcher” role in 2022, officially backdated to 2021. Throughout her tenure at ISS, she became a central figure within the Global Health Center in Rome. Known for her tireless commitment, she often described her career not simply as a job but as a “mission,” emphasizing both her personal and professional passion for making a difference in human health.

🧪 Contributions and Research Focus

Specializing in clinical trials, Dr. Weimer has coordinated and participated in numerous groundbreaking studies in HIV and Hepatitis C (HCV). Since the early 1990s, she has collaborated closely with renowned figures such as Prof. Giovanni Rossi, Prof. Stefano Vella, and Prof. Gianni Rezza, contributing to some of the most pivotal HIV antiretroviral therapy trials in history. Her research efforts extended to co-leading and organizing both national and international multicenter clinical trials. Notably, she has been at the forefront of the PITER study, a major nationwide cohort that follows 25,000 patients undergoing HCV treatment—one of the most comprehensive initiatives in Italy in the fight against hepatitis.

🌍 Global Collaborations and Humanitarian Engagement

Her impact extends beyond Italy, thanks to her active involvement with the U.S.-based American Clinical Trials Group on HIV studies. These collaborations have enhanced international understanding and treatment of HIV/AIDS. In addition to her clinical and research commitments, Dr. Weimer also devoted herself to frontline service during the COVID-19 pandemic. Volunteering both with the Civil Protection unit and at Bambino Gesù Children’s Hospital, she demonstrated profound humanitarian values. Her presence during a critical time underscored her belief in serving communities not just from behind a lab desk but also on the ground, directly supporting patients and health systems under strain.

🏅 Accolades and Recognition

Dr. Weimer’s work has been acknowledged at both national and international levels. One of the most prominent recognitions she received was the 1st Prize at the International Congress on Hepatitis C held in Seville in November 2019, a testament to her excellence and influence in the field of infectious disease research. Her achievements are not only measured in accolades but also in the tangible difference her work has made in advancing therapy options and clinical management of chronic viral diseases. Her rise within the ISS and the trust placed in her leadership of major research projects further affirm her standing within the scientific community.

💡 Impact and Influence

Over the course of her extensive career, Dr. Weimer has significantly shaped clinical research strategies in Italy, especially regarding chronic viral infections. Her coordination of thousands of patient cases within structured clinical trials has informed policy decisions and improved treatment protocols nationwide. Her presence at the ISS has also influenced future generations of researchers and clinicians, many of whom benefited from her mentorship, leadership, and example of scientific integrity. Through her rigorous methods and patient-focused approach, she has played a key role in Italy’s standing as a leader in global health research, especially in relation to HIV and HCV.

🔬 Legacy and Future Contributions

Looking forward, Dr. Weimer’s contributions will continue to echo through the fields of virology and clinical medicine. Her involvement in the PITER cohort and other studies has laid down essential groundwork for long-term epidemiological surveillance and patient care strategies. With her appointment as First Researcher, she enters a new chapter of leadership, likely to drive more innovative, patient-centered research initiatives in global health. Her legacy lies not only in her publications or awards but also in the thousands of lives improved by the treatments she helped to test, refine, and implement. The combination of scientific rigor and heartfelt service defines her enduring contribution to modern medicine.

Publication

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C – TR Morgan, MG Ghany, HY Kim, KK Snow, ML Shiffman, JL De Santo, … – 2010

 

  • Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‐year follow‐up of 150 patients – SL George, BR Bacon, EM Brunt, KL Mihindukulasuriya, J Hoffmann, … – 2009

 

  • Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis – V Saxena, L Nyberg, M Pauly, A Dasgupta, A Nyberg, B Piasecki, … – 2015

 

  • Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy – D Persaud, SC Ray, J Kajdas, A Ahonkhai, GK Siberry, K Ferguson, … – 2007

 

  • Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real‐world cohort study – EB Tapper, BR Bacon, MP Curry, DT Dieterich, SL Flamm, LE Guest, … – 2016

 

  • Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with< 50 copies/ml HIV-1 RNA – S Baroncelli, CM Galluzzo, MF Pirillo, MG Mancini, LE Weimer, … – 2009

 

  • Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study – R Mellado-Artigas, LE Mujica, ML Ruiz, BL Ferreyro, F Angriman, E Arruti, … – 2021

 

  • A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients – M Floridia, R Bucciardini, D Ricciardulli, V Fragola, MF Pirillo, LE Weimer, … – 1999

 

  • Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort – LA Kondili, F Romano, FR Rolli, M Ruggeri, S Rosato, MR Brunetto, … – 2017

 

  • Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER network – LA Kondili, GB Gaeta, D Ieluzzi, AL Zignego, M Monti, A Gori, A Soria, … – 2017

 

🏁 Conclusion

Dr. Weimer stands as a distinguished figure in the field of global health research, with deep expertise in clinical trials and infectious diseases. Her legacy is marked by landmark contributions to HIV and HCV treatment protocols, influential collaborations, and compassionate public service. Her ongoing work continues to shape public health policy and medical research in Italy and beyond. As she advances in her leadership role at the ISS, her experience, insight, and dedication will remain vital to future innovations in clinical research and global health.

Rosario Osta | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof.Dr. Rosario Osta | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Rosario Osta, CIBERNED-Fundación Instituto de Investigación Sanitaria de Aragón-Universidad de Zaragoza,  Spain.

Prof. Rosario Osta Pinzolas is a distinguished geneticist and full professor at the University of Zaragoza, Spain. Her academic roots in veterinary sciences and a Ph.D. in Genetics laid the foundation for a prolific career in biomedical research, particularly in the fields of neuroscience and genetic disorders. With leadership roles in multiple high-profile research consortia such as CIBERNED, TRICALS, and ENCALS, she has established herself as a central figure in neurodegenerative disease research. Her scholarly output includes over 100 indexed publications, multiple national and international research projects, and an h-index exceeding 45.

Profile

Orcid 

Scopus

 

🎓 Early Academic Pursuits

Rosario Osta Pinzolas began her academic journey with a solid foundation in veterinary sciences, graduating as Licenciada en Veterinaria from the University of Zaragoza in 1989. Her academic inclinations quickly shifted toward molecular genetics, leading her to complete a Ph.D. in Genetics at the same university in 1994. Her early studies were driven by a deep curiosity about the mechanisms of heredity and gene expression, setting the tone for a lifelong commitment to biomedical research. These formative years cultivated her scientific rigor and sowed the seeds for a career that would eventually bridge basic science and translational medicine.

🧬 Professional Endeavors in Genetics and Biomedicine

Prof. Osta currently holds the esteemed title of Catedrática (Full Professor) in the Department of Anatomy, Embryology, and Genetics at the Faculty of Veterinary Medicine, University of Zaragoza. Since 2018, she has led her department with a focus on integrative biomedical sciences. She is the principal investigator of the LAGENBIO group recognized by both the Aragon Health Research Institute and the Government of Aragon. Under her leadership, the group has developed two major subprograms: TERAGEN and REGENERAGEN. As coordinator of the “Neuroscience and Mental Health Program” at IISA, she has spearheaded numerous efforts to understand and address neurological diseases through genetic approaches.

🧠 Contributions and Research Focus in Neuroscience

A prominent figure in neuroscience, Prof. Osta’s research lies at the intersection of genetics and neurodegeneration. She is currently the principal investigator of the only Aragon-based group within CIBERNED (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas), reflecting her national influence. Her team represents Zaragoza in prominent European consortia such as TRICALS and ENCALS, both focused on amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. Through more than 100 indexed publications, predominantly in top-tier journals, her work delves into the molecular underpinnings of neurological disorders and explores regenerative medicine strategies, thereby contributing to innovative therapeutic avenues.

🧪 Accolades and Recognition in Scientific Excellence

Prof. Osta’s academic and research career has been punctuated by consistent recognition. She has completed five research productivity periods and one technology transfer period, acknowledged by CNEAI — a mark of sustained scientific impact. She has led over 74 research projects and contributed to more than 100 collaboration contracts, earning her four competitive research awards from respected institutions including CORIS, AREA, IIS, and SEBBM. Her contributions have been lauded not only for scientific quality but also for practical relevance in biomedical advancements.

🚀 Innovation and Impact in Translational Research

An ardent advocate for science with societal impact, Prof. Osta has significantly contributed to technology transfer. She holds nine patents, five of which have been licensed to industry partners. Her collaborations with companies have led to meaningful translational outputs, emphasizing her role in bridging the gap between academic research and real-world solutions. As former Director of the Technology Transfer and Innovation Secretariat at the University of Zaragoza for nearly a decade, she played a crucial role in institutional innovation strategies. Her involvement in joint university-company chairs and her role in the UZ Technology-Based Business Creation Committee for over 12 years further underscore her influence on academic entrepreneurship.

📚 Mentorship and Educational Leadership

Beyond the lab, Prof. Osta has left a profound mark as an educator and mentor. Since 2013, she has coordinated the Interuniversity Doctoral Program in Biomedical and Biotechnological Sciences, a joint initiative between the Universities of Zaragoza and La Rioja. Her mentorship includes the supervision of 13 Ph.D. theses — 9 of which earned international distinction and 6 received extraordinary doctoral awards. Her influence extends to guiding numerous undergraduate and master’s theses, fostering a new generation of scientists with a deep commitment to research excellence and innovation.

🌍 Legacy and Future Contributions

Prof. Rosario Osta’s legacy is defined by her ability to integrate scientific discovery, mentorship, and innovation. As a member of the Scientific Committee of the Luzón Foundation, her vision reaches beyond academia into public health advocacy and strategic research planning. With nearly 19,000 citations on Google Scholar and an h-index of 45, her work continues to inspire and inform global research communities. Her continued leadership in collaborative European projects ensures her contributions will shape the future of neuroscience, genetics, and translational medicine for years to come.

Publication

Title: Novel FKBP prolyl isomerase 1A (FKBP12) ligand promotes functional improvement in SOD1G93A amyotrophic lateral sclerosis (ALS) mice
Authors: L. Moreno-Martinez, N. Gaja-Capdevila, L. Mosqueira-Martín, R. Osta, F.J. Gil-Bea
Year: 2025

Title: Identifying Hub Genes and miRNAs Associated with Alzheimer’s Disease: A Bioinformatics Pathway to Novel Therapeutic Strategies
Authors: E. Gascón, A.C. Calvo, N. Molina, P. Zaragoza, R. Osta
Year: 2024

Title: Comparative Blood Profiling Based on ATR-FTIR Spectroscopy and Chemometrics for Differential Diagnosis of Patients with Amyotrophic Lateral Sclerosis—Pilot Study
Authors: K. Tkachenko, J.M. González Sáiz, A.C. Calvo, R. Osta, C. Pizarro Millán
Year: 2024

Title: Sex differences on constitutive long non-coding RNA expression: Modulatory effect of estradiol and testosterone in muscle cells
Authors: T. López-Royo, L. Moreno-Martinez, L. Moreno-García, R. Manzano, R. Osta
Year: 2024

Title: Differentially expressed lncRNAs in SOD1 G93A mice skeletal muscle: H19, Myhas and Neat1 as potential biomarkers in amyotrophic lateral sclerosis
Authors: T. López-Royo, L. Moreno-Martinez, P. Zaragoza, R. Manzano, R. Osta
Year: 2024

Title: Proteomic profiling of human plasma extracellular vesicles identifies PF4 and C1R as novel biomarker in sarcopenia
Authors: P. Aparicio, D. Navarrete-Villanueva, A. Gómez-Cabello, R. Osta, R. Manzano
Year: 2024

Title: Sporadic Amyotrophic Lateral Sclerosis Skeletal Muscle Transcriptome Analysis: A Comprehensive Examination of Differentially Expressed Genes
Authors: E. Gascón, P. Zaragoza, A.C. Calvo, R. Osta
Year: 2024

Title: Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population
Authors: D. Borrego-Hernández, J.F. Vázquez-Costa, R. Domínguez Rubio, M. Povedano, A. García-Redondo
Year: 2024

Title: New Insights into Endogenous Retrovirus-K Transcripts in Amyotrophic Lateral Sclerosis
Authors: L. Moreno-Martinez, S. Macías-Redondo, M.H.P. Strunk, R. Osta, J. Schoorlemmer
Year: 2024

Title: Analysis of Plasma-Derived Exosomal MicroRNAs as Potential Biomarkers for Canine Idiopathic Epilepsy
Authors: M. García-Gracia, L. Moreno-Martinez, A. Hernaiz, S. García-Belenguer, I. Martín-Burriel
Year: 2024

🏆 Conclusion

Based on her outstanding research contributions, innovation in translational science, mentorship record, and leadership within national and European research programs, Prof. Rosario Osta Pinzolas is an exceptionally strong candidate for the Best Researcher Award. Her profile reflects not only academic excellence but also societal impact and visionary leadership. While there is room for enhanced global outreach, her sustained achievements and contributions make her highly deserving of this prestigious recognition.

Huaqian Xu | Developmental Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Huaqian Xu | Developmental Neuroscience | Best Researcher Award

Mr. Huaqian Xu,  Huazhong University of Science and Technology, China.

Xu Huaqian is a dedicated and accomplished joint master’s and doctoral student at Huazhong University of Science and Technology, specializing in Power Engineering and Engineering Thermophysics. Under the mentorship of Professor Zeng Kuo and Professor Yang Haiping, he has cultivated a strong academic and research foundation focused on high-temperature thermal energy storage. With over 20 published research papers in leading journals such as Energy, Chemical Engineering Journal, and Journal of Energy Storage, Xu has significantly contributed to advancing knowledge in sustainable thermal systems and energy efficiency. He has received multiple prestigious awards including the First-Class Academic Scholarship, Weichai Power Scholarship, Zhixing Scholarship, and the Outstanding Graduate Award, reflecting both academic excellence and research impact.

Profile

Scopus

🎓 Early Academic Pursuits

Xu Huaqian embarked on his academic journey with a keen interest in energy systems and thermal sciences. Demonstrating outstanding aptitude early in his studies, he was admitted into the prestigious joint master’s and doctoral program at Huazhong University of Science and Technology in 2021. This rigorous academic environment, paired with his innate curiosity and analytical mindset, laid a strong foundation for his future contributions in power engineering and engineering thermophysics. Guided by esteemed mentors, Professor Zeng Kuo and Professor Yang Haiping, Xu’s early academic years were marked by intellectual growth, precision in scientific inquiry, and a deepening commitment to sustainable energy research.

🔬 Professional Endeavors

Xu Huaqian’s academic career is complemented by a professional research trajectory that reflects dedication and technical sophistication. His involvement in cutting-edge research within the domain of high-temperature thermal storage has allowed him to bridge theoretical concepts with practical applications. His work contributes to the development of efficient and robust thermal systems crucial for next-generation energy infrastructure. Collaborating with multidisciplinary teams, he has actively participated in high-impact research projects that align with global efforts to address energy security and climate resilience.

🧪 Contributions and Research Focus

Specializing in Power Engineering and Engineering Thermophysics, Xu has focused his research on the challenging yet pivotal area of high-temperature thermal energy storage. His investigations delve into material behavior, system optimization, and thermodynamic performance of storage systems under extreme thermal conditions. Xu’s work not only contributes to the enhancement of renewable energy utilization but also supports the integration of solar thermal and industrial waste heat recovery technologies. With over 20 published research articles in reputed journals like Energy, Chemical Engineering Journal, Journal of Energy Storage, and Journal of the Energy Institute, he has consistently added valuable insights to the academic and industrial discourse on energy efficiency.

🏆 Accolades and Recognition

Xu Huaqian’s scholarly excellence has been widely recognized through numerous prestigious awards. He was honored with the First-Class Academic Scholarship by Huazhong University of Science and Technology, reflecting his top-tier academic standing. In 2023, he received the Weichai Power Scholarship, which acknowledges innovative contributions to the field of energy engineering. Additionally, accolades such as the Zhixing Scholarship and the Outstanding Graduate Award highlight his consistent commitment to excellence and research impact throughout his graduate education.

🌍 Impact and Influence

Through his prolific publishing record and focus on critical energy challenges, Xu has begun to establish a strong presence in the international research community. His studies have the potential to reshape how industries and energy providers view thermal energy storage, especially in the context of decarbonization and grid flexibility. Xu’s influence extends beyond the academic realm, touching on environmental sustainability and policy implications. His work encourages cross-sector collaboration, enabling innovations that can power industries more cleanly and efficiently.

🧠 Legacy and Future Contributions

Looking ahead, Xu Huaqian is poised to be a thought leader in sustainable thermal technologies. As the global demand for reliable and eco-friendly energy solutions intensifies, his research is expected to play a central role in developing scalable, high-performance energy storage systems. He is likely to contribute not only through future publications and patents but also by mentoring the next generation of energy scientists and engineers. His academic legacy will be marked by a steadfast dedication to science-driven innovation and societal advancement.

⚡ Advancing the Frontiers of Thermal Energy Science

At the intersection of engineering thermophysics and sustainable development, Xu Huaqian’s work exemplifies the potential of scientific research to solve pressing global problems. Whether through enhancing the efficiency of renewable energy storage systems or developing materials capable of withstanding high thermal loads, his work continues to push the boundaries of what is possible in the energy domain. With an unwavering focus on innovation and societal impact, Xu represents a new wave of researchers committed to building a smarter, cleaner energy future.

Publication

  • Title: Investigation of metal foam enhancement under multilayer interaction for large-scale latent heat storage

  • Authors: Zheyu Fang, Kuo Zeng, Huaqian Xu, Haiping Yang, Hanping Chen

  • Year: 2025

  • Journal: Energy

 

📝 Conclusion

Xu Huaqian emerges as a promising figure in the field of energy research, particularly in the area of high-temperature thermal storage technologies. His blend of scientific rigor, innovative thinking, and strong academic mentorship positions him to make enduring contributions to the energy sector. Through his research, Xu not only addresses technical challenges in thermal engineering but also aligns with global sustainability goals. His achievements and ongoing work indicate a future filled with impactful discoveries and leadership in the advancement of clean and efficient energy systems.

Chen Shoubin | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Chen Shoubin | Behavioral Neuroscience | Best Researcher Award

Dr. Chen Shoubin, Shenzhen University,  China.

Dr. Shoubin Chen is a forward-thinking Research Fellow at the Guangdong Laboratory of Artificial Intelligence and Digital Economy (Shenzhen), affiliated with Shenzhen University. With a Ph.D. in Photogrammetry and Remote Sensing, his career has been rooted in the intersection of spatial intelligence, robotics, and AI. From leading national research projects to publishing in reputable journals and securing multiple invention patents, Dr. Chen has made substantial contributions to the field of embodied intelligent robotics. His research emphasizes multi-sensor fusion and autonomous mapping, aiming to give machines human-like spatial perception and decision-making capabilities.

Profile

Google Scholar

 

📚 Early Academic Pursuits

Shoubin Chen’s academic journey began with a strong foundation in geospatial sciences, culminating in a Ph.D. in Photogrammetry and Remote Sensing in 2020. This prestigious degree was awarded through a rigorous joint training program between Wuhan University and the Finnish Geospatial Research Institute. During his doctoral studies, he developed a deep interest in integrating advanced spatial data techniques with artificial intelligence, laying the groundwork for his future research endeavors. His early academic phase was marked by a commitment to cross-border scientific collaboration and multidisciplinary exploration, which has since defined his research approach.

🧑‍💻 Professional Endeavors

Currently serving as a Research Fellow and graduate supervisor at the Guangdong Laboratory of Artificial Intelligence and Digital Economy (Shenzhen) and Shenzhen University, Dr. Chen plays a pivotal role in advancing embodied intelligence within the Spatial Intelligence Team. His responsibilities include mentoring postgraduate students, overseeing cutting-edge research, and steering major national and provincial scientific projects. He has contributed to several national-level initiatives, including two National Natural Science Foundation of China grants, support from the China Postdoctoral Science Foundation, and sub-projects under the National Key Research and Development Program. These experiences have sharpened his expertise in high-precision robotic mapping and autonomous navigation.

🤖 Contributions and Research Focus

Dr. Chen’s primary research focus lies in embodied intelligent robotics, with an emphasis on multi-sensor fusion, robotic perception, and spatial mapping technologies. He is recognized for integrating data from various sensing modalities to improve the autonomy and spatial awareness of robotic systems. His innovations aim to empower robots with human-like spatial understanding, allowing them to operate reliably in complex environments. This research direction is crucial for applications ranging from autonomous vehicles to intelligent service robots, contributing significantly to the frontier of AI-driven robotics.

🏅 Accolades and Recognition

Throughout his academic and professional career, Shoubin Chen has garnered considerable recognition for his scientific excellence. He has published nearly ten high-quality papers as either the first or corresponding author in SCI Q2 journals and CCF B-tier or higher conferences and journals. Moreover, he has applied for over ten invention patents, underscoring his commitment to both theoretical advancement and practical application. His reputation in the academic community is further highlighted by his service as a peer reviewer for prestigious platforms such as the IEEE Internet of Things Journal, Remote Sensing of Environment, IEEE Transactions on Intelligent Vehicles, and ICRA, one of the top robotics conferences globally.

🌐 Impact and Influence

Dr. Chen’s work has had a profound impact on the fields of AI, robotics, and spatial computing. His multi-disciplinary approach has influenced how robots understand and interact with their environments, offering transformative possibilities in smart cities, autonomous transport, and digital mapping. By fusing photogrammetry with robotics and AI, he has contributed to a new paradigm in spatial intelligence that bridges digital perception and physical action. His projects have not only generated academic outputs but have also driven technological innovations with potential for real-world deployment.

🌱 Legacy and Future Contributions

As a mentor, innovator, and research leader, Shoubin Chen continues to inspire the next generation of scientists and engineers in AI and robotics. His forward-looking vision involves deepening the integration of embodied intelligence with environmental understanding, enabling machines to collaborate more intuitively with humans. He is poised to expand his research to include human-robot interaction, sustainable urban intelligence, and smart sensing systems. With a growing portfolio of publications, patents, and mentorship experiences, his contributions are set to leave a lasting legacy in the development of intelligent systems that seamlessly bridge perception and action.

🔬 Vision in Artificial Intelligence and Robotics

Guided by a vision that combines spatial science with artificial cognition, Dr. Chen’s work embodies the future of AI-powered robotics. His pursuit of intelligent, context-aware robotic systems aligns with global goals in automation, smart infrastructure, and digital economy. As AI becomes increasingly pervasive in everyday life, his contributions are steering the technology toward safer, more efficient, and more interactive systems. Through continuous innovation and collaboration, he remains at the forefront of a transformative research frontier that blends engineering precision with visionary thinking.

Publication

  • Title: Exploring embodied multimodal large models: Development, datasets, and future directions
    Authors: S Chen, Z Wu, K Zhang, C Li, B Zhang, F Ma, FR Yu, Q Li
    Year: 2025

 

  • Title: Distributed Robust Communication-Efficient Multi-Robot SLAM Combining Real-Time Intersection and Historical Loop Constraints
    Authors: B Zhang, Z Xiong, J Qiu, S Chen, Y Hu, S Chen
    Year: 2025

 

  • Title: TextGeo-SLAM: A LiDAR SLAM With Text Semantics and Geometric Constraints-Based Loop Closure
    Authors: S Chen, C Li, Q Jiang, X Zhuang, B Zhang, B Zhou, Q Li
    Year: 2024

 

  • Title: ASL-SLAM: A LiDAR SLAM with activity semantics-based loop closure
    Authors: B Zhou, C Li, S Chen, D Xie, M Yu, Q Li
    Year: 2023

 

  • Title: Comparative analysis of SLAM algorithms for mechanical LiDAR and solid-state LiDAR
    Authors: B Zhou, D Xie, S Chen, H Mo, C Li, Q Li
    Year: 2023

 

  • Title: Research on SLAM based on LiDAR/visual fusion (LV-SLAM)
    Authors: C Shoubin
    Year: 2023

 

  • Title: Cooperative smartphone GNSS/PDR for pedestrian navigation
    Authors: C Jiang, Y Chen, C Chen, S Chen, Q Meng, Y Bo, J Hyyppa
    Year: 2022

 

  • Title: Indoor Attitude Estimation Using Equipped Gyroscopes and Depth Sensors
    Authors: Q Shi, Z Song, Z Xiao, S Chen, F Wang
    Year: 2022

 

  • Title: LI-SLAM: Fusing LiDAR and Infrared Camera for Simultaneous Localization and Mapping
    Authors: B Zhou, D Xie, S Chen, C Li, H Mo
    Year: 2022

 

  • Title: NDT-LOAM: A real-time LiDAR odometry and mapping with weighted NDT and LFA
    Authors: S Chen, H Ma, C Jiang, B Zhou, W Xue, Z Xiao, Q Li
    Year: 2021

 

✅ Conclusion

In conclusion, Dr. Shoubin Chen exhibits all the core qualities of a Best Researcher Award recipient: deep scientific insight, proven research leadership, strong publication and patent output, and a visionary approach to solving real-world problems through AI and robotics. While there are opportunities to grow his international footprint, his current accomplishments already place him among the leading young researchers in his field. Based on the evidence of impact, innovation, and research excellence, he is highly suitable for the Best Researcher Award.

Hao Lai | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Hao Lai | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Hao Lai, Zhongshan Hospital, Fudan University, China.

Dr. Hao Lai is a distinguished cardiovascular surgeon and researcher, currently serving as Chief Physician at Zhongshan Hospital, Fudan University. With over 20 years of clinical expertise, he specializes in aortic and cardiovascular surgery. His academic achievements include a Ph.D. in Surgery from Fudan University and significant contributions to the study of epigenetic mechanisms in thoracic aortic dissection. As a principal investigator of nationally funded projects and co-author of influential publications, Dr. Lai combines scientific rigor with clinical innovation. He has also played a key role in medical education and device development through industry collaboration.

Profile

Scopus

 

🎓 Early Academic Pursuits

Dr. Hao Lai began his academic journey with a strong foundation in medical sciences, culminating in a Ph.D. in Surgery from the prestigious Fudan University. His early academic pursuits were marked by a deep interest in cardiovascular physiology and surgical intervention, which later matured into a specialized focus on aortic diseases. His time as a doctoral candidate not only equipped him with rigorous scientific training but also ignited his lifelong commitment to solving complex clinical problems through research.

🏥 Professional Endeavors

Currently serving as Chief Physician at Zhongshan Hospital, Fudan University, Dr. Hao Lai has accumulated over two decades of extensive clinical experience in cardiovascular and aortic surgery. His professional trajectory reflects a seamless integration of surgical excellence with academic leadership. At Zhongshan Hospital, a leading institution in China, he has spearheaded several clinical programs aimed at enhancing patient outcomes in cases of thoracic aortic dissection and other high-risk cardiovascular conditions.

🔬 Contributions and Research Focus

Dr. Lai’s research centers around the epigenetic mechanisms underlying thoracic aortic dissection, with a particular focus on histone modification and DNA methylation. He is the Principal Investigator of a major research project funded by the National Natural Science Foundation of China, which explores the role of H3K36me3 histone modification and DNMT3B-mediated gene body methylation in the pathogenesis of aortic dissection. His scientific efforts bridge molecular pathology with clinical implications, offering new perspectives on the diagnosis and treatment of life-threatening vascular disorders.

🏆 Accolades and Recognition

A respected voice in cardiovascular medicine, Dr. Hao Lai has co-authored numerous influential articles in high-impact journals such as Cardiovascular Research and Advanced Science. His h-index of 18, as listed on Scopus, reflects his consistent scholarly output and the wide academic acknowledgment of his work. In addition, his authorship of the textbook Practical Surgery (3rd Edition), published by People’s Medical Publishing House, stands as a testament to his educational contributions to the next generation of Chinese surgeons.

🧪 Impact and Innovation

Dr. Lai’s research has made a tangible impact on the understanding and treatment of aortic diseases. His investigation into the epigenetic regulation of vascular pathology has opened new avenues for targeted therapies. Moreover, his collaboration with MicroPort Endovascular MedTech demonstrates his commitment to translating research findings into real-world applications, particularly in the development and refinement of endovascular surgical devices.

🌍 Influence and Collaboration

Beyond his direct research and surgical contributions, Dr. Lai’s influence extends into collaborative domains, both nationally and internationally. His leadership in high-level research grants, clinical trials, and industrial partnerships positions him as a central figure in the evolving landscape of cardiovascular surgery. His collaborative spirit fosters innovation and promotes cross-disciplinary dialogue, essential in today’s complex medical research environment.

🔮 Legacy and Future Contributions

As Dr. Hao Lai continues his distinguished career, his legacy is being shaped not only by his surgical accomplishments but also by his contributions to medical science. His ongoing projects are likely to further clarify the molecular landscape of aortic diseases and inspire new therapeutic strategies. Looking ahead, Dr. Lai is poised to remain at the forefront of cardiovascular innovation, committed to improving patient care through a synthesis of research, education, and clinical practice.

Publication

 

Title: Prevalence and predictors of left atrial thrombus in patients with rheumatic atrial fibrillation undergoing cardiac surgery: a cross-sectional study
Authors: J. Cui, Y. Zhang, Y. Wang, Q. Ji, C. Wang
Year: 2025


Title: A novel open-vascular single-branched stent graft in total arch repair of type A aortic dissection one-year results of a prospective multicenter randomized controlled study
Authors: J. Gu, W. Zhang, L. Kang, H. Lai, C. Wang
Year: 2025


Title: Fibroblast Activation Protein Acts as a Biomarker for Monitoring ECM Remodeling During Aortic Aneurysm via 68Ga-FAPI-04 PET Imaging
Authors: C. Hu, H. Tan, Y. Zhang, X. Chen, L. Wang
Year: 2025


Title: Mitochondrial NAD+ deficiency in vascular smooth muscle impairs collagen III turnover to trigger thoracic and abdominal aortic aneurysm
Authors: J. Zhang, Y. Tang, S. Zhang, K. Zhu, W. Zhang
Year: 2025


Title: Correcting mitochondrial loss mitigates NOTCH1-related aortopathy in mice
Authors: Y. Tang, J. Zhang, Y. Fang, Y. Xu, W. Zhang
Year: 2025


Title: Exploration of 68Ga-FAPI-04 PET/MR in Chronic Type B Aortic Dissection
Authors: C. Hu, Y. Zhang, S. Qiu, H. Shi, L. Wang
Year: 2025


Title: Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: A randomized controlled trial
Authors: M. Luo, J. Luo, X. Xu, G. Tu, Z. Luo
Year: 2024


Title: Therapeutic results of three-dimensional aortic valve anatomic repair for regurgitant bicuspid aortic valve
Authors: J. Li, C. Wang, Z. Zuo, W. Ding, T. Hong
Year: 2024


Title: 68Ga-FAPI-04 Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Ascending Aortic Aneurysm
Authors: C. Hu, H. Tan, Y. Zhang, H. Lai, L. Wang
Year: 2024


Title: Sex-based outcomes after thoracic endovascular aortic repair: A systematic review and meta-analysis
Authors: Y. Zhang, Y. Zhang, Y. Wang, L. Wang, Q. Ji
Year: 2025

✅ Conclusion

Dr. Hao Lai’s career represents a powerful blend of surgical precision, scientific insight, and academic leadership. His work has advanced the understanding of aortic diseases at the molecular level while improving surgical outcomes for patients. As he continues to mentor, innovate, and lead research at the intersection of epigenetics and cardiovascular pathology, Dr. Lai’s contributions are set to leave a lasting legacy in both clinical practice and medical science.